SUBJECT

Title

Health technology assessment

Type of instruction

lecture

Level

master

Credits

4

Recommended in

Semester 2

Typically offered in

Spring semester

Course description
  • Components of HTA
  • Multicriteria decision analysis
  • HTA implementation in high income countries
  • Operation of HTA agencies; Joint HTA at European level
  • HTA implementation in lower income countries
  • Transferability of HTA
  • Evidence synthesis / systematic literature review
  • Collection of local data
  • Critical appraisal of health technology assessment
  • HTA of special technologies: medical devices and diagnostics
  • HTA of technologies in rare diseases
  • HTA of preventive medicine
Readings
  • Drummond et al:  Principles for the improved conduct of health technology assessment for resource allocation decisions, International Journal of Technology Assessment in Health Care, 24:3 (2008), 244–258.
  • MCDA for Health Care Decision Making – An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
  • Epstein D. The use of Comparative Effectiveness Research and Health Technology Assessment in European countries: current situation and prospects for the future http://www.ugr.es/~davidepstein/HTA%20in%20european%20countries.docx    
  • Kaló Z, Gheorghe A, Huic M, Csanádi M, Kristensen FB. HTA implementation roadmap in Central and Eastern European countries. Manuscript accepted for publication in Health Economics, 2015
  • Drummond M, Augustovski F, Kaló Z, Yang BM, Pichon-Riviere A, Bae EZ, Kamal-Bhl S. Challenges faced in transferring economic evaluations to middle income countries. Int J Tech Assess HC, manuscript accepted for publication, 2016
  • Inotai A, Pékli M, Jóna G, Nagy O, Remák E, Kaló Z. Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology. BMC Health Serv Res. 2012. 21. 12. 1. 332.
  • Toumi M, Pashos CL, Korchagina D, Redekop K, Morel T, Blanchette C, Kaló Z, Simoens S, Gatermann R, Molsen E. Challenges in Assessing and Appraising Rare Disease Diagnostics & Treatments, ISPOR SIG Report 2015
  • Inotai A, Pékli M, Jóna G, Nagy O, Remák E, Kaló Z. Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology. BMC Health Serv Res. 2012. 21. 12. 1. 332.